MedTrace Logo

Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis

NCT03467035 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2018-03-15

No results posted yet for this study

Summary

The objectives of this research grant are to determine the association of hypoxia with the severity of osteoporosis in the patients with bronchiectasis and whether the mechanism of inflammation is triggered by inflammasones, which makes it more prone to osteoporosis in patients with bronchiectasis.

Conditions

  • Bronchiectasis Adult
  • Osteoporosis, Osteopenia

Interventions

OTHER

Inflammasone

Serum level of cytokine and RT-PCR for PBMC

Sponsors & Collaborators

  • Chun-Hua Wang, MD

    lead OTHER

Principal Investigators

  • Chun-Hua Wang · Chang Chung Memorial Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-21
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03467035 on ClinicalTrials.gov